DD228266A5 - Verfahren zur herstellung von wff-analoga - Google Patents

Verfahren zur herstellung von wff-analoga Download PDF

Info

Publication number
DD228266A5
DD228266A5 DD84266649A DD26664984A DD228266A5 DD 228266 A5 DD228266 A5 DD 228266A5 DD 84266649 A DD84266649 A DD 84266649A DD 26664984 A DD26664984 A DD 26664984A DD 228266 A5 DD228266 A5 DD 228266A5
Authority
DD
German Democratic Republic
Prior art keywords
gln
leu
arg
ala
gly
Prior art date
Application number
DD84266649A
Other languages
German (de)
English (en)
Inventor
Peter Bohlen
Paul E Brazeau
Frederick St Esch
Ling Nicholas Chai-Kwan
William B Wehrenberg
Roger Ch L Guillemin
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/527,292 external-priority patent/US4610976A/en
Priority claimed from US06/541,167 external-priority patent/US4585756A/en
Priority claimed from US06/585,814 external-priority patent/US4605643A/en
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Publication of DD228266A5 publication Critical patent/DD228266A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DD84266649A 1983-08-29 1984-08-27 Verfahren zur herstellung von wff-analoga DD228266A5 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/527,292 US4610976A (en) 1983-08-29 1983-08-29 Porcine GRF
US06/541,167 US4585756A (en) 1983-10-12 1983-10-12 Bovine GRF
US06/585,814 US4605643A (en) 1984-03-02 1984-03-02 Ovine GRF

Publications (1)

Publication Number Publication Date
DD228266A5 true DD228266A5 (de) 1985-10-09

Family

ID=27414960

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84266649A DD228266A5 (de) 1983-08-29 1984-08-27 Verfahren zur herstellung von wff-analoga

Country Status (20)

Country Link
EP (1) EP0137689B1 (cs)
JP (1) JPH0676437B2 (cs)
KR (1) KR900006560B1 (cs)
AR (1) AR248284A1 (cs)
AU (1) AU577542B2 (cs)
CS (1) CS251085B2 (cs)
DD (1) DD228266A5 (cs)
DE (1) DE3461641D1 (cs)
DK (1) DK161835C (cs)
EG (1) EG17263A (cs)
ES (1) ES8606401A1 (cs)
FI (1) FI81589C (cs)
GR (1) GR80227B (cs)
HU (1) HU190973B (cs)
IE (1) IE57730B1 (cs)
IL (1) IL72717A (cs)
NO (1) NO167867C (cs)
PT (1) PT79094B (cs)
SU (1) SU1423000A3 (cs)
YU (1) YU45907B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518586A (en) * 1983-01-13 1985-05-21 The Salk Institute For Biological Studies GRF Analogs III
IL70530A (en) * 1983-01-13 1986-09-30 Salk Inst For Biological Studi Synthetic peptides having growth hormone releasing factor activity and compositions containing them
DE3436819A1 (de) * 1984-10-06 1986-04-17 Hoechst Ag, 6230 Frankfurt Arzneimittel mit grf-wirkung
DK173350B1 (da) * 1985-02-26 2000-08-07 Sankyo Co Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
AU599922B2 (en) * 1985-09-10 1990-08-02 Natinco Nv Improving carcass quality
US4880778A (en) * 1986-05-12 1989-11-14 Eastman Kodak Company Combinations having synergistic growth hormone releasing activity and methods for use thereof
EP0289186A3 (en) * 1987-04-23 1990-04-04 International Minerals And Chemical Corporation Process for increasing the growth rate and enhancing the feed efficiency of meat producing livestock
FR2622455B1 (fr) * 1987-11-04 1991-07-12 Agronomique Inst Nat Rech Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes
JPH01174387A (ja) * 1987-12-28 1989-07-10 Onoda Cement Co Ltd ヤギの成長ホルモン
US7468273B2 (en) 2003-05-01 2008-12-23 Meial Limited Canine GHRH gene, polypeptides and methods of use
JP2008500010A (ja) * 2003-05-01 2008-01-10 メリアル リミテッド イヌ科動物のghrh遺伝子、ポリペプチド及び使用方法
AU2015346277B2 (en) * 2014-11-12 2020-03-26 Centre Hospitalier Universitaire De Liège Treatment of hormonal disorders of growth
US10697238B2 (en) * 2015-09-04 2020-06-30 Pica Corp. Telescopic device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ204456A (en) * 1982-06-16 1987-05-29 Salk Inst For Biological Studi Synthetic pancreatic growth-hormone releasing factor
IL70530A (en) * 1983-01-13 1986-09-30 Salk Inst For Biological Studi Synthetic peptides having growth hormone releasing factor activity and compositions containing them
AU575843B2 (en) * 1983-08-10 1988-08-11 The Administrators Of The Tulane Eductional Fund Growth hormone releasing peptides

Also Published As

Publication number Publication date
EP0137689A1 (en) 1985-04-17
IE57730B1 (en) 1993-03-24
IE842199L (en) 1985-02-28
KR850001536A (ko) 1985-03-30
DK413084D0 (da) 1984-08-29
NO167867C (no) 1991-12-18
EP0137689B1 (en) 1986-12-10
YU45907B (sh) 1992-09-07
DK161835C (da) 1992-01-20
GR80227B (en) 1985-01-02
AU577542B2 (en) 1988-09-29
AR248284A1 (es) 1995-07-12
ES535455A0 (es) 1986-04-01
FI81589B (fi) 1990-07-31
AU3244984A (en) 1985-03-07
YU148884A (en) 1988-04-30
NO167867B (no) 1991-09-09
FI81589C (fi) 1990-11-12
CS251085B2 (en) 1987-06-11
ES8606401A1 (es) 1986-04-01
HU190973B (en) 1986-12-28
JPH0676437B2 (ja) 1994-09-28
DK161835B (da) 1991-08-19
DE3461641D1 (en) 1987-01-22
PT79094B (en) 1986-08-14
HUT35000A (en) 1985-05-28
EG17263A (en) 1991-08-30
KR900006560B1 (ko) 1990-09-13
JPS6072900A (ja) 1985-04-24
SU1423000A3 (ru) 1988-09-07
IL72717A (en) 1988-01-31
FI843355A0 (fi) 1984-08-24
PT79094A (en) 1984-09-01
NO843381L (no) 1985-03-01
IL72717A0 (en) 1984-11-30
DK413084A (da) 1985-03-01
FI843355L (fi) 1985-03-01

Similar Documents

Publication Publication Date Title
US4518586A (en) GRF Analogs III
CA1243016A (en) Human grf peptide analogs
US4528190A (en) GRF Analogs IV
EP0299402B1 (de) LHRH Antagonisten, deren Herstellung und entsprechende pharmazeutische Zubereitungen
DE69534852T2 (de) Verbesserte zyclische crf agonisten
US4517181A (en) Mammalian PGRF
US4529595A (en) GRF Analogs
US4626523A (en) GRF analogs II
US4585756A (en) Bovine GRF
DE68914205T2 (de) Zyklische GRF-Analoge.
EP0023192A1 (de) Cyclopeptide und pharmazeutische Präparate davon, sowie Verfahren zu ihrer Herstellung und deren Anwendung
US4610976A (en) Porcine GRF
EP0117034B1 (en) Grf analogs
EP0031303A2 (de) Cyclooctapeptide und pharmazeutische Präparate davon, sowie Verfahren zur Herstellung derselben und ihre Anwendung
US4595676A (en) Rat hypothalamic GRF
US4628043A (en) Hypothalamic GRF agonists
US4605643A (en) Ovine GRF
US4728726A (en) GRF analogs IIIb
JP2758901B2 (ja) Grf類似体▲vii▼
EP0137689B1 (en) Grf analogs
DE69025123T2 (de) Grf-viia-analoge
EP0107890B1 (en) Mammalian pgrf
US4703035A (en) Human pancreatic GRF amidated fragments
DE68913273T2 (de) CRF vom Fisch.
CA1271899A (en) Grf analogs

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee